Tag: AIC
AIC expands ability to serve patients
January 20, 2025HME News Staff
DALLAS – AIC, a division of AIS Healthcare, now offers ALYGLO, manufactured by GC Biopharma, for the treatment of adult patients with primary humoral immunodeficiency (PI). This new immunoglobulin (Ig) therapeutic option will expand the company’s ability to better serve PI patients in their home or an infusion suite setting. “We are excited to add ALGYLO to our expansive list of Ig infusion therapies,” said Jud Hall, president of AIC. “AIC is proud to partner with GC...
AIC adds new drugs
March 25, 2024HME News Staff
DALLAS – AIC, a division of AIS Healthcare, now offers GLASSIA and ARALAST NP, manufactured by Takeda, for the treatment of adult patients with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-antitrypsin deficiency). The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting. “We’re excited and proud to be able to...